Table: Kringle Pharma - Q1 parent results

Kringle Pharma

09/02/2026 06:40

Feb 9 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Dec 31, 2025        Dec 31, 2024       Sep 30, 2026  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            18 mln              18 mln             72 mln     
                 (+2.2 pct)          (-2.8 pct)         (-0.3 pct)   
  Operating     loss 199 mln        loss 212 mln        loss 1.17    
  Recurring     loss 200 mln        loss 212 mln        loss 1.17    
  Net           loss 201 mln        loss 212 mln        loss 1.17    
  EPS          loss 28.20 yen      loss 31.23 yen    loss 162.18 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T